Immunome, Inc.

IMNM·NasdaqCM·Healthcare
Compare
19.15−0.40 (−2.05%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close19.55
Open19.42
Day range19.0819.73
52-week range13.5430.06
Off day high−2.94%
Off 52-week high−36.29%
Volume835.70K
Avg. volume (3M)1.20M
Market cap2.26B
EPS (TTM)-2.57
Forward P/E-7.89
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.56
Shares outstanding118.00M
Short interest17.25% of float
Earnings dateNov 5, 2026 (est.)
Analyst target35.20
Profit margin0.00%

Against its peers

Compare in full ›
IMNM IDYA IMTX IMCR PYXS IOVA
Market cap 2.26B 3.48B 1.10B 1.50B 240.11M 6.60B
P/E (TTM) — — — — — —
Forward P/E -7.9 -9.0 -3.5 -38.5 -1.8 -67.9
Price/book 4.1 2.9 2.2 3.6 11.2 9.0
Dividend yield — — — — — —
1-year change +35.82% +33.21% −29.11% −8.45% −37.77% +586.79%
Today −2.05% −0.14% −2.96% −1.19% −0.99% −0.41%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All IMNM news ›
Markets Daily·Negative

Immunome (NASDAQ:IMNM) Stock Price Down 6.6% – What’s Next?

Posted by Michael Walen on Oct 8th, 2026 Immunome, Inc. (NASDAQ:IMNM – Get Free Report) shares dropped 6.6% during mid-day trading on Tuesday. The company traded as low as $19.84 and last traded at $19.7820. Approximately 448,182 shares…

@gurufocus·Negative

Immunome (IMNM) Gains FDA IND Clearance for IM-1340 Targeting Ad

On September 30, 2026, Immunome Inc (NASDAQ: IMNM) announced that the U.S. Food and Drug Administration has authorized its Investigational New Drug (IND) application for IM-1340, a novel antibody-drug conjugate designed to treat advanced…

From articles in the 4Search news index.

In the news

7mentions in 30 days
7with it in the headline
Mixedsentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.